Expression of p53 and Glutathione S-Transferase-π Relates to Clinical Drug Resistance in Non-Small Cell Lung Cancer.

MLA

Nakanishi, Yoichi, et al. “Expression of P53 and Glutathione S-Transferase-π Relates to Clinical Drug Resistance in Non-Small Cell Lung Cancer.” Oncology, vol. 57, no. 4, Nov. 1999, pp. 318–23. EBSCOhost, https://doi.org/10.1159/000012068.

APA

Nakanishi, Y., Kawasaki, M., Bai, F., Takayama, K., Pei, X.-H., Takano, K., Inoue, K., Osaki, S., Hara, N., & Kiyohara, C. (1999). Expression of p53 and Glutathione S-Transferase-π Relates to Clinical Drug Resistance in Non-Small Cell Lung Cancer. Oncology, 57(4), 318–323. https://doi.org/10.1159/000012068

Chicago

Nakanishi, Yoichi, Masayuki Kawasaki, Fen Bai, Koichi Takayama, Xin-Hai Pei, Koichi Takano, Koji Inoue, Sin-ichi Osaki, Nobuyuki Hara, and Chikako Kiyohara. 1999. “Expression of P53 and Glutathione S-Transferase-π Relates to Clinical Drug Resistance in Non-Small Cell Lung Cancer.” Oncology 57 (4): 318–23. doi:10.1159/000012068.